Ownership Submission

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0104

Estimated average burden hours per response...

0.5

(Print or Type Responses)

1. Name and Address of Reporting Person ^*

Cosendai Gregoire

2. Date of Event Requiring Statement (Month/Day/Year)
11/18/2014

3. Issuer Name and Ticker or Trading Symbol
SECOND SIGHT MEDICAL PRODUCTS INC [EYES]

(Last)

(First)

(Middle)

12744 SAN FERNANDO ROAD, BUILDING 3

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

_____ Director	_____ 10% Owner
__X__ Officer (give title below)	_____ Other (specify below)
VP of European Operations

5. If Amendment, Date Original Filed(Month/Day/Year)

(Street)

SYLMAR, CA 91342

6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	0	D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Option ⁽¹⁾	⁽¹⁾	11/01/2018	Common Stock	20,000	$ 5	D
Option ⁽²⁾	⁽²⁾	02/01/2019	Common Stock	5,081	$ 5	D
Option ⁽³⁾	⁽³⁾	05/01/2019	Common Stock	10,000	$ 5	D
Option ⁽⁴⁾	⁽⁴⁾	02/01/2020	Common Stock	6,480	$ 5	D
Option ⁽⁵⁾	⁽⁵⁾	02/01/2020	Common Stock	5,100	$ 5	D
Option ⁽⁶⁾	⁽⁶⁾	06/01/2020	Common Stock	1,700	$ 5	D
Option ⁽⁷⁾	⁽⁷⁾	12/01/2020	Common Stock	25,000	$ 5	D
Option ⁽⁸⁾	⁽⁸⁾	03/01/2021	Common Stock	4,987	$ 5	D
Option ⁽⁹⁾	⁽⁹⁾	03/01/2022	Common Stock	3,875	$ 5	D

Reporting Owners

Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Cosendai Gregoire 12744 SAN FERNANDO ROAD, BUILDING 3 SYLMAR, CA 91342			VP of European Operations

Signatures

/s/ Gregoire Cosendai		11/18/2014
^**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	4,000 options vested on each November 1, 2009, November 1, 2010, November 1, 2011, November 1, 2012 and November 1, 2013.
(2)	1,026.20 options vested on each February 1, 2010, February 1, 2011, February 1, 2012, February 1, 2013 and February 1, 2014.
(3)	2,000 options vested on each May 1, 2010, May 1, 2011, May 1, 2012, May 1, 2013 and May 1, 2014.
(4)	1,620 options vested on each February 1, 2011, February 1, 2012, February 1, 2013 and February 1, 2014.
(5)	1,275 options vested on each February 1, 2011, February 1, 2012, February 1, 2013 and February 1, 2014.
(6)	426 options vested on each June 1, 2011, June 1, 2012, June 1, 2013 and June 1, 2014.
(7)	6,250 options vested on each December 1, 2011, December 1, 2012, December 1, 2013 and December 1, 2014.
(8)	1,662.50 options vested on each March 1, 2012, March 1, 2013 and March 1, 2014.
(9)	1,937.50 options vested on each March 1, 2013 and March 1, 2014.
Remarks: Excludes unvested options, and shares underlying unvested options of 70,804 shares, not vested and not exercisable for over 60 days from this date.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.